key: cord-0858064-19bpnn9n
authors: Raham, T. F.
title: Do low TB prevalence or lack of BCG VaccinationContribute to Emergence Multisystem Inflammatory Syndrome?
date: 2020-07-21
journal: nan
DOI: 10.1101/2020.07.18.20156893
sha: 73a43f8d4266dbe8e8c569520be039ef5305ecc2
doc_id: 858064
cord_uid: 19bpnn9n

Background: Emergence of new multisystem inflammatory syndrome in children (MIS-C) is thought to be associated with COVID-19 pandemic. Covid-19 morbidity and mortality variances among countries has been suggested by previous works to be influenced BCG and previous Latent TB infection (which is reflected by TB prevalence) by possible inducing heterogeneous immunity against SARS-COV2. Aim: To examine influence of BCG status and TB prevalence on variances among countries which register new multisystem inflammatory syndrome in children (MIS-C). Methods: We choose all countries which report MIS-C till 23/6/2020, number of cases for each 10 million capita was examined among 3 categories of countries classified according to BCG program status. TB prevalence, MIS-C no. / 10 million (M) and Covid- 19 deaths/M are taken as markers. Receiver operation characteristic - (ROC) curve, as well as some relative indicators such as (sensitivity and specificity rates), estimation area of trade - off between sensitivity and specificity, and cutoff points are used for discriminating different three pairs of countries (which have different BCG practices). Discrimination of these categories done through studied markers. 95% confidence interval of all probable combinations pairs had been measured. Results: MIS-C No/10 M capita in countries never gave BCG vaccination vs countries currently give vaccine shows area under ROC- curve equal to 0.000 with a symbiotic significant of 0.034 and (95% CI interval of 0.000-0.000) also MIS-C No/10 M capita in countries not currently give BCG vaccination ( with previous mass vaccination programs) vs countries currently give mass vaccination shows area under ROC- curve equal to 0.094 with a symbiotic significant of 0.027and ( 95% CI interval of 0.000 -0.280) Important not significant finding in MIS-C No/10 M capita in countries never gave BCG vaccination vs countries not currently give vaccine shows area under ROC- curve equal to 0.583 with a symbiotic significant of 0.683 and (95% CI interval of 0.074-0.759). Countries not currently give vaccine make discrimination in other pairs COVID-19 deaths M capita in countries never gave BCG vaccination vs countries currently give vaccine shows area under ROC- curve equal to 0.083 with a symbiotic informative and reportable value of 0.077 and (95% CI interval of 0.000-0.309 also COVID-19 deaths M capita in countries not currently give BCG vaccination vs countries currently giving vaccine shows area under ROC- curve equal to 0.188 with a symbiotic informative reportable value of 0.089 and ( 95% CI interval of 0.000-0.452). Important finding is the not significant association in COVID-19 deaths /M capita in countries never gave BCG vaccination vs countries not currently giving vaccine area under ROC- curve equal to 0.417 with a symbiotic significant of 0.683 and (95% CI interval of 0.078 - 0.755). Countries not currently giving vaccine make discrimination in third pair of countries in significant association and not in 1st pair. Regarding TB prevalence marker or discriminator the areas under curve were informative and reportable and too generating with the leftover markers in all 3 pairs signifying inverse relations with covide-19 mortality and MIS-C no. curves . Conclusion: BCG vaccinations and high TB prevalence are found in this study to be related to decrease MIS-C and COVID-19 deaths this might explain variances among countries worldwide. Further studies to confirm this relations and possible relations with other epidemics is recommended. Review of TB programs in relation to treat latent asymptomatic infections and initiate and consolidate BCG programs should be considered urgently.

In April of 2020, reports emerged from the United Kingdom of a presentation in children similar to incomplete Kawasaki disease (KD) or toxic shock syndrome 1 ,2,3 . In Italy, approximately 10 suspected Kawasaki-like disease cases have been recorded since 1 January 2020, eight of which were reclassified as new Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection in children (PIMS-TS) 4 or multisystem inflammatory syndrome in children (MIS-C) or paediatric hyper inflammatory syndrome, or paediatric hyper inflammatory shock 1 . Classical KD with concurrent COVID-19 also have been reported 5 . MIS-C is hyper inflammatory syndrome with multiorgan involvement have some features similar to those of Kawasaki disease and toxic shock syndrome (KDSS) 6 .

(KD) is an acute febrile systemic vasculitis that predominantly occurs in children younger than 5 years of age and the most common acquired heart disease during childhood in most industrialized countries 7 and is the most common primary vasculitis in childhood, with medium and small sized arteries predominantly affected 8 . The annual incidence of KD is highest in Japan, with more than 300 per 100 000 children aged 4 years or younger affected 9 , compared with 25 per 100 000 children aged 5 years or younger in North America 10 and is rarely reported in sub-Saharan Africa 11 . Although KD is less common in western countries 12 KD shock syndrome ( KDSS) a rare form of KD has a higher incidence in these countries 13 (2.60 to 6.95%) 14,12,15 ,compared with Asian countries like Taiwan which reported lower incidence rate (1.45%) 16 .

KDSS is often associated with myocarditis and requires critical care support during the acute phase of illness KDSS might mimic toxic shock syndrome 12 .

A high level of circulating pro-inflammatory cytokines might contribute to the distributive component of shock. Indeed, KDD has been found associated with high levels of IL-6, , and procalicitonin 13 .Patient with MIS-C also high levels of inflammatory markers, including leucocytosis with a predominance of neutrophils, in addition to high levels of C reactive protein, ESR ,procalcitonin, and serum interleukin 6 17 . Furthermore elevation of inflammatory markers (cytokines) has been previously demonstrated in inflammatory state for multiple conditions 18 including cytokine storms. Cytokine storm denotes a hyperactive immune response characterized by the release of interferons, interleukins, tumor-necrosis factors, chemokines, and several other mediators. These mediators are part of a well-conserved innate immune response necessary for efficient clearance of infectious agents. Cytokine storm implies that the levels of released cytokines are injurious to host cells 19,20 . Cytokine storms can be caused by a number of infectious, especially viral respiratory infections such as H5N1,H1N1 influenze and SARS-CoV 21,22 Other causative agents include the Epstein-Barr virus, cytomegalovirus 23 . Likewise in KD circumstantial evidence points to an infectious cause 24 . In the past 20 years, viruses of the coronavirus family have been proposed as possibly implicated in the pathogenesis of Kawasaki disease. 25, 26 It is said that case definition of MIS-C is quite broad and overlaps with Kawasaki disease, and other conditions like juvenile rheumatoid arthritis 27 . On the contrary some experts are concerned that current diagnostic criteria may not capture the true scope of the problem. 28 The severity of inflammation in KD is reflected by inflammatory parameters; thus, laboratory findings are helpful for diagnosing incomplete KD just like MIS-C. A child is considered to have incomplete KD when there are fewer than 4 clinical features in the presence of fever 1 . "Atypical KD" should be used in the presence of an unusual or odd manifestation of KD (e.g., nephritis or central nervous system complication) 29 . Incomplete KD is considered to be a mild form of KD 30 . Nevertheless, such children may have significant coronary artery sequelae as the diagnosis and treatment are often delayed 31 .

Differences in Kawasaki shock syndrome and MIS warrants studies investigating underlying immunological mechanisms. Kawasaki disease in its milder form is prevalent in Asian countries. Furthermore, sever form of KDSS, sever covid-19 and MIS-C observed in western countries while milder in Asian and sub-Saharan Africa.

Cardiac manifestations in MIS might mimic Kawasaki or Kawasaki shock syndrome and include myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities other clinical features may overlap.

American Heart Association as a significant finding among the diagnostic guidelines for KD 32 . Such finding might account to 50%of patients 33,34 . In spite of that no study done before to show BCG effectiveness in KD disease process. BCG reactivation is thought to happen due to suggested cross reactivity of mycobacterial Heat Shock Protein 65 (HSP65) and the human homologue HSP63. Furthermore, cross immune heterogeneity was suggested between BCG and many viral diseases and neonatal sepsis. Since early months of covid -19 pandemic and forward literatures suggest the role of BCG in decreasing the severity and mortality of COVID-19 and possibly morbidity. Furthermore, annual a symptomatic latent TB infection might play a natural role like BCG in protecting communities with high TB prevalence.

This study is the first in this aspect handling MIS-C incidence in relation to BCG, TB prevalence and COVID-19 deaths.

At early times during COVID-19 pandemic heterogeneous immunity towards (SARS-CoV-2), was hypothesized and statistical correlation between of (BCG vaccination practices and TB prevalence ) and COVID-19 mortality among countries was statistically confirmed. They suggest that BCG (attenuated Mycobacterium bovis) and possibly previous latent or active TB caused by Mycobacterium tuberculosis) have heterogeneous immunity to certain pathogens other than Mycobacterium tuberculosis effect.

As far as Mycobacterium bovis through BCG has heterogeneous effects to various microorganisms and possibly to SARS-COV2 and possible relation of low TB prevalence to high covid-19 mortality I put the question of this paper in such way : if BCG programs and TB prevalence affects MIS-C morbidity. This study might gain its importance because of no study was done about MIS-C relation to TB prevalence or BCG vaccination and to possible relation between them. This might open the door to furtherly identify relations with KDSS ,KD or other hyperimmune serous conditions.

Data regarding to MIS-C collected till 23/6/2010 in all countries which register MIS. Then Covid-19 deaths/Million registered as it appeared on public data accessed on 2/7/2020 . Countries BCG practices were put in three different groups :

1-No vaccination at all and no previous BCG 2-no current vaccination but with previous vaccination program (ceased BCG vaccinations previously), and 3-currently giving mass BCG vaccine through national program . Total countries were 15, distributed among that groups status as shown in table No. (1). Covid -19 mortality, data TB prevalence data, and population data are obtained from publically published data. BCG data are obtained from publically available WHO data and various references.

Receiver operation characteristic -(ROC) curve, as well as some relative indicators such as (sensitivity and specificity rates), and cutoff points are used for discriminating different three categories of countries (which have different BCG practices).

Discrimination of these categories done through studied markers. All statistical operations were performed through using the ready-made statistical package SPSS, ver. 22. 

We present the results of each BCG status pair for the three BCG groups : Table No. (2) shows estimates area of trade -off between sensitivity and specificity of markers through plotting sensitivity against a complement specificity outcome to examine that trade -off, which is called (ROC) curve, as well as a significant level for testing area under the guideline of fifty percent, with 95% confidence interval of all probable combinations pairs of countries as follows:

The common think in this pair is that both groups had no vaccination programs at this time whether had previous history of vaccinations or not.

currently vaccinated (y axis). In order to create a cut-off points for the markers searched between the three pairs of classifiers in relative with BCG practices, and some screening tests such as sensitivity, and specificity rates are presented in 

It is clear that TB prevalence cutoff points are more in 3d pair then 2 nd pair both of these pairs have current countries with BCG vaccination programs.

Regarding MIS-C there is strong relations with BCG status being effective in decreasing incidence in countries currently give BCG vaccine with partial effect on those with previous vaccination programs . countries never gave BCG vaccine being mostly affected. 

Analyses should go retrograde to look for possible epidemiological links to look for evidence of such temporal associations.

In 1 9 1 8 pandemic although cytokine storm was hypothesized but no report or for Kawasaki or Kawasaki like syndrome 1918 pandamic ,but some analyses have shown the virus to be particularly deadly because it triggers a cytokine storm, which ravages the stronger immune system 73 . 74 . Even so some patients in China were complicated with bronchitis, pneumonia, and even hemolysis . Erythema was found in some patients were usually misdiagnosed as scarlet fever 74 75 .Furthermore during 2009 pandemic Influenza virus rash is uncommon, and a rare cause of petechial rash in severely affected children were described 76 . According to that the rash associated to Chinese patient more likely is rash of Influenza A as to Dr A. Stanley said rather than to disease related to Kawasaki or Kawasaki like.The low mortality and morbidity among Chinese people were attributed to Chinese herbals 74 .

Kingdom and USA 77 . 84 . For reasons that were unclear, infection rates were highest in some camps .Severity statistics were striking: 95 843 measles cases occurred, 22 809 (23·8%) people were admitted to hospital for complications, and 3206 (3.34%) people died. At Camp Pike (Little Rock, AR) they thought that this measles is thought to have killed more soldiers than the 1918 influenza pandemic 84 . These findings make me think that MIS-C like disease might be back to 1917 due to possible relation to H1N1 spanish flu in mechanisem similar to what happens now with SARS-COV2, specially these bronchopneumonias showed similar streptococcal pathological changes and seem to have been associated with previous respiratory viral infections 85, 86 presumably including seasonal influenza and other viruses 84 .Some of these deaths documented not only specific to postmeasles pneumonias because an epidemic of severe and fatal primary pneumonia or empyema, or both, in soldiers without measles, which paralleled the measles case-fatality rather than measles incidence 84 .

In recent MIS-C pandemic skin rash is common in more than half reported rash, as the NYC Health Department said 89 .

Tuberculosis mortality was in decline in the US since at least the mid-nineteenth century. The overall decline was greatly thought to be accelerated by the 1918 pandemic , but as far as the process would have continued, albeit more slowly, even if the 1918 pandemic had not occurred 90 make me think that the decrease in TB is possibly related to high mortality and complication due to Spanish flue rather than opposite explanation although this should be documented .Here in this paper we show that both TB prevalence and BCG status have influence on both covid-19 mortality and MIS-C incidence. Is TB through latent or previous infection or through BCG vaccination has cross immunity protection against covid-19 pandemic and other influenza pandemics making these pandemics more sever in western countries and such severity affect adults and children. Is it probable that when TB prevalence starts to decrease in Asia some sort By the 1950s, the first effective antimicrobial drugs against TB (i.e., streptomycin, paraamino salicylic acid, and isoniazid) had been developed. This help in reducing the prevalence of TB in many countries 92 .

Up to my knowledge there is no study done to answer the question of sudden drop of TB prevalence to emergence of Kawasaki disease in Japan or to study the low rate of KDSS compared to Europe which most of countries have low TB prevalence and variations in BCG program practices. According to our work we find a influence of BCG vaccination on covid 19 deaths and IMS-C in a strong relation experts are looking for increase in KD in Asian countries at this time ,but this might needs time according to history of previous epidemics and outbakes. 106 . TB prevalence again is higher than Japan might explain lower incidence of KD in China compared to Japan.

In Europe, the epidemiology of KD ranges from 3.6 to 15.2/100,000. 107 but ( KDSS) has a higher incidence in these countries 13 ,compared with Asian countries the real cause for high incidence of KDSS in western countries is unknown yet. Low TB prevalence and lack of BCG vaccination might put these countries to report higher rate of KDSS.

BCG unlike natural infection gives protection to 50%-60 % 110 of target population. This might possibly have explained prevalence of KD when TB prevalence start to decrease in communities to relatively medium level of TB prevalence possibly due to presence of BCG vaccinations In contrast higher rate of KDSS are found in unvaccinated communities and lower TB prevalence although KD is lower than Asian countries. We found here in this paper higher incidence of IMS-C associated with low TB prevalence countries and associated with lack of BCG programs. The incidence of IMS-C vary within European countries possibly due to variations in BCG recommendations concerning its use in Europe as follows: 111 

As far as this study shows a strong relation between BCG and MIS-C, between BCG prevalence and COVID -19 deaths, and between TB prevalence and MIS-C and between TB prevalence and COVID-19 deaths so our recommendation is that BCG vaccination clinical trials are required to corroborate the patterns detected here, and to establish causality between BCG vaccination and protection from severe COVID-19 and possibly other epidemics.

There is no conflict of interest.

There is no funding received. 

Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records

Kawasaki disease: an epidemiological study in central Italy

Incidence of Kawasaki disease in northern European countries

Geographic distribution of Kawasaki disease throughout Chile

The epidemiology and clinical features of Kawasaki disease in Australia

Kawasaki Disease in Catalonia Working Group Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain

Epidemiologic survey of Kawasaki disease in Inner Mongolia

Kawasaki disease in Germany: a prospective, population-based study adjusted for underreporting

Twelve years of Kawasaki disease in Portugal: epidemiology in hospitalized children

Five years of Kawasaki disease in the Netherlands: a national surveillance study

Kawasaki disease: a prospective population survey in the UK and Ireland from

Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand

Rheumatic fever and Kawasaki disease among children in Israel

Kawasaki disease at a pediatric hospital in Mexico

Kawasaki disease: Epidemiology and etiology . www.uptodate.com ©2020 UpToDate

Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in Children

The site of origin of the 1918 influenza pandemic and its public health implications

What happened in China during the 1918 influenza pandemic?

Acute fever and petechial rash associated with influenza A virus infection

Imad MD Petechial Rash With Pandemic Influenza (H1N1) Infection

Age-specific mortality during the 1918 influenza pandemic: Unravelling the mystery of high young adult mortality

Origins of the 1918 Pandemic: The Case for France

Flu epidemic traced to Great War transit camp". The Guardian. UK. Archived from the original on 12

The so-called Great Spanish Influenza Pandemic of 1918 may have originated in France in 1916

A hypothesis: the , gas, pigs, ducks, geese and horses in northern France during the Great War provided the conditions for the emergence of the "Spanish" influenza pandemic of 1918-1919" (PDF)

Contagion and Chaos

A brief summary of the viral statistics of the US Army during the World War

A forgotten epidemic that changed medicine: measles in the US Army

Communicable diseases in the National Guard and National Army of the United States during the six months from

Pneumonia and some of its complications at Camp Bowie

The Medical Department of the United States Army in the World War. Volume XII. Pathology of the acute respiratory diseases, and of gas gangrene following war wounds

Pneumonia at a base hospital

Kawasaki-like Inflammatory Disease Affects Children With COVID-19. Diagnostic and Interventional Cardiology

The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: An age, period, cohort analysis

Infectious Diseases Control (Tuberculosis, Parasitic Disease, Immunization Programs) in : Japan's Experiences in Public Health and Medical Systems

Achievements in and Challenges of

A Historical Perspective of Influenza A(H1N2) Virus,Emerging infectious Diseases2014

Antigenic variation of recent influenza A(H1N1) viruses

15252#:~:text=Kawasaki%20disease%20could%20be%20the,National%20Academy%20of%20Sciences1

The burden and challenges of tuberculosis in China: findings from the Global Burden of Disease Study

Kawasaki disease: an epidemiological study in central Italy

Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines

TB Prevalence Influence onCovid-19 Mortality

The efficacy f and infants in the prevention of tuberculosis: Meta-analyses of the published literature

European Centre for Disease Prevention and Control: Vaccine Schedule

Infectious Diseases of Luxembourg